Inventor · disambiguated record
Jinhyuk Fred Chung
Also filed as: CHUNG JINHYUK · CHUNG JINHYUK FRED
1 granted patent·10 pending applications·0 citations·filing 2005–2025
14Inventor score
Files withXYLONIX PTE LTD5XYLONIX IP HOLDINGS PTE LTD3CHUNG JINHYUK FRED1COLON WILFREDO1NANOMEDICINE RES CO LTD1
Top patents by PatentIndex Score
11 records- 0152US2025041333A1Gamma-polyglutamic acid and zinc compositionsXYLONIX PTE LTD·Filed 2024·Application pending·0 cites
- 0251US2025025496A1Zinc-[gamma]-pga compositions and methods for treating cancerXYLONIX PTE LTD·Filed 2024·Application pending·0 cites
- 0340US11944640B2Zinc-[gamma]-PGA compositions and methods for treating cancerXYLONIX PTE LTD·Filed 2017·Granted Apr 2, 2024·0 cites·6 claims
- 0439US2021128609A1Oncology treatments using zinc agentsXYLONIX IP HOLDINGS PTE LTD·Filed 2019·Application pending·0 cites
- 0537US2010119608A1Synthesis of pH-sensitive, Acid-Stable Metal-Binding NanoparticlesCHUNG JINHYUK FRED·Filed 2008·Application pending·0 cites
- 0636US2010124571A1Use of pH-sensitive, Acid-Stable Metal-Binding NanoparticlesNANOMEDICINE RES CO LTD·Filed 2008·Application pending·0 cites
- 0735US2024181089A1Pharmaceutical polymer conjugatesXYLONIX PTE LTD·Filed 2022·Application pending·0 cites
- 0834US2025213609A1Oncology treatments using zinc agentsXYLONIX PTE LTD·Filed 2025·Application pending·0 cites
- 0931US2006183802A1Compositions and methods for treating amyotrophic lateral sclerosis (ALS)COLON WILFREDO·Filed 2005·Application pending·0 cites
- 1026US2020254013A1Compositions comprising alpha-polyglutamic acid-zinc for treating cancerXYLONIX IP HOLDINGS PTE LTD·Filed 2018·Application pending·0 cites
- 1124US2019247428A1Gamma-polyglutamic acid and zinc compositionsXYLONIX IP HOLDINGS PTE LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jinhyuk Fred Chung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →